Sujets obèses sans anomalies métaboliques

ESSER, Nathalie; Scheen, André

Download

Article (Scientific journals)

Sujets obèses sans anomalies métaboliques

ESSER, Nathalie; Scheen, André

2009 • In Revue Médicale de Liège, 64 (3), p. 148-157

Peer reviewed

Permalink
https://hdl.handle.net/2268/12426

PubMed
19418934

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

200903_06.pdf

Publisher postprint (882.32 kB)

Download

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Keywords :

Metabolically Obese Normal Weight; Visceral adipose tissue; Obesity; Metabolic syndrome

Abstract :

[en] Obesity, especially abdominal obesity, is the main risk factor of metabolic syndrome. However, there are obviously non obese individuals who are metabolically abnormal and therefore exposed to an increased risk of cardiovascular complications. Unfortunately, those persons fail to be detected because of a falsely reassuring body weight. The present paper aims at better understanding the etiopathogenesis and pathophysiology of this particular phenotype, at evaluating its potential clinical consequences and at describing the main principles of its therapeutic management.

Disciplines :

Endocrinology, metabolism & nutrition

Author, co-author :

ESSER, Nathalie

Scheen, André ; Université de Liège - ULiège > Département des sciences cliniques > Diabétologie, nutrition et maladie métaboliques - Médecine interne générale

Language :

French

Title :

Sujets obèses sans anomalies métaboliques

Alternative titles :

[en] Metabolically normal obeses subjects

Publication date :

2009

Journal title :

Revue Médicale de Liège

ISSN :

0370-629X

eISSN :

2566-1566

Publisher :

Hopital de Baviere, Liège, Belgium

Volume :

Issue :

Pages :

148-157

Peer reviewed :

Peer reviewed

Additional URL :

http://www.rmlg.ulg.ac.be

Available on ORBi :

since 07 May 2009

Statistics

Number of views

163 (10 by ULiège)

Number of downloads

433 (5 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

Bibliography

Scheen AJ.-Le syndrome métabolique : physiopatho-logie et traitement. In : Athérosclérose Athérothrombose (Eds : Kulbertus H., Van Mieghem W.), Transmed Medical Communications, Lubbeek, Belgium, 2006, 161-190.
Rorive M, Letiexhe MR, Scheen AJ, Ziegler O.-Obésité et diabète de type 2. Rev Med Liège, 2005, 60, 374-382.
Beck E, Scheen AJ.-Sujets 〈métaboliquement obèses〉 sans excès de poids : un phénotype interpellant. Rev Med Liège, 2009, 64, sous presse
Ruderman N, Chisholm D, Pi-Sunyer X, Schneider S.-The metabolically obese, normal-weight individual revisited. Diabetes, 1998, 47, 699-713.
Brochu M, Tchernof A, Dionne IJ, et al.-What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women? J Clin Endocrinol Metab, 2001, 86, 1020-1025.
Sims EA.-Are there persons who are obese, but metabolically healthy ? Metabolism, 2001, 50, 1499-1504.
Karelis AD, St-Pierre DH, Conus F, et al.-Metabolic and body composition factors in subgroups of obesity: what do we know? J Clin Endocrinol Metab, 2004, 89, 2569-2575.
Karelis AD.-Metabolically healthy but obese individuals. Lancet, 2008, 372, 1281-1283.
Wildman RP, Muntner P, Reynolds K, et al.-The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering. Prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med, 2008, 168, 1617-1624.
Stefan N, Kantartzis K, Machann J, et al.-Identification and characterization of metabolically benign obesity in humans. Arch Intern Med, 2008, 168, 1609-1616.
Kelishadi R, Cook SR, Esmaeil M, et al.-Metabolically obese normal weight and phenotypically obese metabolically normal youths: the CASPIAN study. J Am Diet Assoc, 2008, 108, 82-90
Scheen AJ.-Evaluation de l'insulinosécrétion et de l'insulinosensibilité chez l'homme. Thérapie, 2007, 62, 311-318.
Park YW, Zhu S, Palaniappan L, et al.-The metabolic syndrome : prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med, 2003, 163, 427-436.
Ford ES.-Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. Diabetes Care, 2005, 28, 2745-2749.
Meigs JB, Wilson PWF, Fox CS, et al.-Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab, 2006, 91, 2906-2912.
Marchesini G, Melchionda N, Apolone G, et al.-The metabolic syndrome in treatment-seeking obese persons. Metabolism, 2004, 53, 435-440.
Iacobellis G, Ribaudo MC, Zappaterreno A, et al.-Prevalence of uncomplicated obesity in an Italian obese population. Obes Res, 2005, 13, 1116-1122.
Aguilar-Salinas CA, Garcia Garcia E, Robles L, et al.-High adiponectin concentrations are associated with the metabolically healthy obese phenotype. J Clin Endocrinol Metab, 2008, 93, 4075-4079.
Guerre-Millo M.-Adiponectin : an update. Diabetes Metab, 2008, 34, 12-18.
Bonora E, Kiechl J, Oberhollenzer F, et al.-Prevalence of insulin resistance in metabolic disorders: the Brun-neck study. Diabetes, 1998, 47, 1643-1650.
Reaven G.-All obese are not created equal: insulin resistance is the major determinant of cardiovascular disease in overweight/obese individuals. Diab Vasc Dis Res, 2005, 2, 105-112.
McLaughlin T, Allison G, Abbasi F, et al.-Prevalence of insulin resistance and associated cardiovascular disease risk factors among normal weight, overweight, and obese individuals. Metabolism, 2004, 53, 495-499.
Ferrannini E, Natali A, Bell P, et al.-Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR). J Clin Invest, 1997, 100, 1166-1173.
Magis D, Geronooz I, Scheen AJ.-Tabagisme, insuli-norésistance et diabète de type 2. Rev Med Liège, 2002, 57, 575-581.
Magis D, Jandrain BJ, Scheen AJ.-Alcool, sensibilité a l'insuline et diabete sucre. Rev Med Liege, 2003, 58, 501-507.
Hayes L, Pearce MS, Unwin NC.-Lifecourse predictors of normal metabolic parameters in overweight and obese adults. Int J Obes (Lond), 2006, 30, 970-976.
Colombo O, Villani S, Pinelli G, et al.-To treat or not to treat : comparison of different criteria used to determine whether weight loss is to be recommended. Nutr J, 2008, 7, 5.
Janssen I, Katzmarzyk PT, Ross R.-Waist circumference and not body mass index explains obesity-related health risk. Am J Clin Nutr, 2004, 79, 379-384 29. Buemann B, Astrup A, Pedersen O, et al.-Possible role of adiponectin and insulin sensitivity in mediating the favorable effects of lower body fat mass on blood lipids. J Clin Endocrinol Metab, 2006, 91, 1698-1704
Snijder MB, Dekker JM, Visser M, et al.-Larger thigh and hip circumferences are associated with better glucose tolerance : the Hoorn Study. Obes Res, 2003, 11, 104-111.
Freedland ES.-Role of a critical adipose tissue threshold (CVATT) in metabolic syndrome: implication of controlling dietary carbohydrates: a review. Nutr Metab (Lond), 2004, 1, 12.
Succurro E, Marini MA, Frontoni S, et al.-Insulin secretion in metabolically obese, but normal weight, and in metabolically healthy but obese individuals. Obesity, 2008 16, 1881-1886.
Karelis AD, Faraj M, Bastard JP, et al.-The metabolically healthy but obese individual presents a favorable inflammation profile. J Clin Endocrinol Metab, 2005, 90, 4145-4150.
Shin MJ, Hyun YJ, Kim OY, et al.-Weight loss effect on inflammation and LDL oxidation in metabolically healthy but obese (MHO) individuals: low inflammation and LDL oxidation in MHO women. Int J Obes Relat Metab Disord, 2006, 30, 1529-1534.
Karelis AD, Messier V, Brochu M, Rabasa-Lhoret R.-Metabolically healthy but obese women: effect of an energy-restricted diet. Diabetologia, 2008, 51, 1752-1754.
Wajchenberg BL.-Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev, 2000, 21, 697-738.
Després JP.-Is visceral obesity the cause of the metabolic syndrome? Ann Med, 2006, 38, 52-63.
Snijder MB, Zimmer PZ, Visser M, et al.-Independent and opposite associations of waist and hip circumferences with diabetes, hypertension and dyslipidemia: the AusDiab Study. Int J Obes Relat Metab Disord, 2004, 28, 402-409.
Boorsma W, Snijder MB, Nijpels G, et al.-Body composition, insulin sensitivity, and cardiovascular disease profile in healthy Europeans. Obesity, 2008, Oct 16 [Epub ahead of print].
Abbasi F, Chu JW, Malendola C, et al.-Discrimination between obesity and insulin resistance in the relationship with adiponectin. Diabetes, 2004, 53, 585-590.
Landsberg L.-Body fat distribution and cardiovascular risk. A tale of 2 sites. Arch Intern Med, 2008, 168, 1607-1608.
The DECODE Study Group.-Does the constellation of risk factors with and without abdominal adiposity associate with different cardiovascular mortality risk? Int J Obes Relat Metab Disord, 2008, 32, 757-762.
Marini MA, Succurro E, Frontoni S, et al.-Metabolically healthy but obese women have an intermediate cardiovascular risk profile between healthy nonobese women and obese insulin-resistant women. Diabetes Care, 2007, 30, 2145-2147.
Scheen AJ.-The future of obesity: new drugs versus lifestyle interventions ? (Editorial). Exp Opin Invest Drugs, 2008, 17, 263-267.
Scheen AJ, Paquot N.-Effets bénéfiques de l'activité physique sur les facteurs de risque cardio-vasculaire. Rev Med Liege, 2001, 56, 239-243.
Messier V, Malita FM, Rabasa-Lhoret R, et al.-Association of cardiorespiratory fitness with insulin sensitivity in overweight and obese postmenopausal women: a Montreal Ottawa New Emerging Team study. Metabolism, 2008, 57, 1293-1298.